Want to see CLVR full AI Analyst Report?
Clever Leaves Holdings (CLVR) AI Stock Analysis
Clever Leaves Holdings
(Other OTC:CLVR)
Clever Leaves Holdings faces substantial financial performance challenges, primarily due to ongoing net losses and cash flow issues despite some improvements in gross margins. The strong balance sheet offers some stability, but technical analysis and valuation scores are limited by lack of data and negative profitability. Earnings call insights are neutral, providing little additional impact.
Clever Leaves Holdings (CLVR) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $19.65K
- Dividend Yield
- ―
- Average Volume (3M)
- 506
- Price to Earnings (P/E)
- 0.0
- Beta (1Y)
- 7169.16
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- US
- Employees
- 296
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Clever Leaves Holdings Business Overview & Revenue Model
Company Description
Clever Leaves Holdings Inc. is a company primarily focused on the cannabis sector. Its operations are structured into two distinct divisions: Cannabinoid and Non-Cannabinoid. The Cannabinoid segment oversees the global cultivation, extraction, manufa...
How the Company Makes Money
Clever Leaves Holdings generates revenue through its diversified business model, which includes the sale of cannabis extracts, such as CBD and THC oils, as well as dried flower and finished goods to pharmaceutical companies, consumer brands, and othe...
Clever Leaves Holdings Risk Analysis
Clever Leaves Holdings disclosed 49 risk factors in its most recent earnings report. Clever Leaves Holdings reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksClever Leaves Holdings Peers Comparison
Overall Rating
SNDL55Neutral
TLRY46Neutral
CLVR46Neutral
IMCC37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 55Neutral | $301.72M | -7.03 | -5.50% | ― | -2.49% | 32.03% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 46Neutral | $373.90M | -1.82 | -9.38% | ― | 15.93% | 93.85% | |
| 46Neutral | $19.65K | 0.00 | -55.39% | ― | ― | ― | |
| 37Underperform | $1.30M | -0.03 | 841.81% | ― | -11.91% | -285.26% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CLVR | Clever Leaves Holdings, Inc. | 0.01 | -0.01 | -45.00% | |
| TLRY | Tilray | 2.65 | -10.15 | -79.30% | |
| SNDL | Sndl Inc. | 1.35 | -0.50 | -27.03% | |
| IMCC | Im Cannabis Corp | 0.72 | -39.18 | -98.19% | |
| AKAN | Akanda Corp | 1.08 | -30.42 | -96.57% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Jan 02, 2025